Dan is based in the Centre for Applied Pharmacokinetic Research (CAPKR), with research interests in quantitative translation of in vitro data to predict in vivo pharmacokinetic endpoints. Dr Scotcher has particular expertise in the use of physiologically-based pharmacokinetic (PBPK) modelling to mechanistically describe and predict drug disposition in health and disease.
After a brief time working in the pharmaceutical industry, Dan completed his PhD at the University of Manchester in 2016, and then visited the US Food and Drug Administration as an ORISE research fellow. He returned to Manchester as a Research Associate working on an Innovative Medicines Initiative project on Translational Imaging in Drug Safety Assessment, and was subsequently appointed as Lecturer in 2019.
Dan is Deputy Director of the MSc in Model-Based Drug Development, and also contributes to the teaching of the MPharm Pharmacy course.